Efficacy and Safety of Pomalidomide and Dexamethasone in RRMM Patients With Renal Insufficiency (Q64348614)
Jump to navigation
Jump to search
clinical trial
Language | Label | Description | Also known as |
---|---|---|---|
English | Efficacy and Safety of Pomalidomide and Dexamethasone in RRMM Patients With Renal Insufficiency |
clinical trial |
Statements
A Phase 2 Multicenter, Open-label Study to Determine the Efficacy and Safety of Pomalidomide (CC-4047) in Combination With Low-Dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma and Moderate or Severe Renal Impairment Including Subjects Undergoing Hemodialysis (English)
0 references
28 February 2014
0 references
27 January 2017
0 references
81
0 references
18 year
0 references